-Knowledge of the population in regards to stroke has clinical and epidemiological importance. Prompt identification of the symptoms means efficient medical attendance within the window of therapeutic opportunities reducing significantly the morbi-mortality. Our aim was to evaluate the level of knowledge of the population of Teresina (PI) concerning factors of risk, symptoms and treatment of stroke. The door-to-door study was carried out by means of a standardized application of questionnaire on risk factors, symptoms and attitude when faced with a stroke victim. 991 forms were selected. Conhecimento sobre doenças cerebrovasculares em uma população urbana no Brasil RESUMO -O conhecimento da população sobre doenças cerebrovasculares (DCV) possui importância clíni-ca e epidemiológica. A rápida identificação dos sintomas significará atendimento médico eficiente dentro das janelas de oportunidades terapêuticas reduzindo significativamente a morbimortalidade. Objetivou-se avaliar o nível de conhecimento da população de Teresina (PI) acerca dos fatores de risco, sintomas e tratamento das DCV. O estudo populacional, porta-a-porta, foi conduzido mediante aplicação padronizada de um questionário sobre fatores de risco, sintomas e atitude diante de um caso de DCV.
Several studies have demonstrated a high prevalence of depression and anxiety in patients with systemic lupus erythematosus (SLE); however, few data address gender differences regarding these manifestations. This study aimed to investigate gender differences in the prevalence of depressive and anxiety symptoms, and their effect on the quality of life (QOL) of male and female SLE patients. This study included 54 male SLE patients, 54 female SLE patients, 54 male controls and 54 female controls. Depressive symptoms were assessed using the Beck Depression Inventory (BDI), the Center for Epidemiologic Studies Depression Scale (CES-D) and the Hospital Anxiety and Depression Scale (HADS); the anxiety symptoms were examined using HADS. We used the Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) to assess QOL. Depressive symptoms were found in 22.2% of BDI respondents, 24.1% of CES-D respondents and 13% of HADS-D respondents who were male SLE patients; while in the female SLE patient group, they were found in 38.9% of BDI respondents (p = 0.063), 51.9% of CES-D respondents (p = 0.653) and 31.5% of HADS-D respondents (p = 0.003). Anxiety symptoms were found in 16.7% of the male SLE patients and 38.9% of the female SLE patients (p = 0.024). Lower scores on the SF-36 (for QOL) were found in both male and female SLE patients with depression and anxiety symptoms. In conclusion, we observed significant gender differences regarding the prevalence of depressive and anxiety symptoms in patients with SLE, with significantly higher values in the female group. The presence of these symptoms appears to have a negative effect on the QOL of patients of both genders.
Neuropsychiatric lupus (NPSLE) is described in 12-95% of patients with systemic lupus erythematosus (SLE). Anxiety disorders are among the most frequent manifestations of NPSLE, occurring in 4-85% of these patients. Several diagnostic tools, such as Hospital Anxiety and Depression Scale (HADS), have been used to assess anxiety in clinical studies in SLE, but there is a lack of data on the performance of these questionnaires in the disease. This study aimed to assess the performance of HADS for the detection of anxiety in male and female patients with SLE, also investigating possible gender differences in this aspect. This study included 54 male SLE patients and 54 female SLE patients. The Diagnostic Criteria for Generalized Anxiety Disorder of the 5th edition of the Diagnostic and Statistical Manual of Mental Disorders was used as gold-standard method to assess the performance of HADS for detecting anxiety in SLE patients. HADS presented sensitivity of 88.9% and specificity of 92.6%, with positive and negative predictive values of 80.0 and 96.1%, respectively. The HADS accuracy in total sample was 92.6%, with Kappa coefficient equal to 0.5794 (95% CI 0.3894-0.7695). No significant differences were observed between female and male groups regarding the performance of HADS for diagnosing anxiety.
Na atualidade a morte tem vindo a ser remetida para o hospital em detrimento do espaço íntimo do lar. As unidades de cuidados intensivos são altamente tecnológicas, abertas e destituídas de privacidade, onde a morte é um fenómeno frequente, algumas vezes inesperado, mas quase sempre traumático. Neste contexto, o enfermeiro é confrontado com diversos dilemas e emoções que podem comprometer a sua saúde mental e condicionar os cuidados que presta a alguém em final de vida. OBJETIVOS: Explorar e descrever a experiência da morte e do morrer vivida pelos enfermeiros numa unidade de cuidados intensivos e de compreender o significado que lhe atribuem. MÉTODOS: Optámos pela realização de um estudo qualitativo, exploratório e descritivo, de base fenomenológica. Os participantes (N=25) foram selecionados por conveniência tendo a amostra sido atingida por saturação teórica. Os dados foram recolhidos com recurso à entrevista não estruturada e analisados segundo a reflexão fenomenológica das narrativas, segundo a perspetiva de van Manen (2016). RESULTADOS: Da análise das narrativas emergiram cinco temas: condicionantes da perceção dos enfermeiros sobre a morte e o morrer; práticas e contextos de cuidados ao doente em morte iminente; práticas e contextos de cuidados à família; mecanismos de adaptação; e conflitos internos na gestão dos cuidados. CONCLUSÕES: Estes resultados permitem uma compreensão mais abrangente do objeto em estudo e orientam as intervenções dos enfermeiros para um cuidado centrado na pessoa, digno e confortador para a família e doentes que se confrontam com a morte neste e noutros contextos.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.